Flurazepam
NADAC/unit
N/A
Active Shortage
Tier 1: 4.0%
PA Req: 0.6%
2 Manufacturers
4 ANDAs
Active Shortages
2022-08-03 Shortage reported, Chartwell Molecular Holdings LLC
2022-08-03 Shortage reported, Chartwell Molecular Holdings LLC
2022-08-03 Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility., Rising Pharma Holdings, Inc.
2022-08-03 Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility., Rising Pharma Holdings, Inc.
2022-08-03 Shortage reported, Chartwell Molecular Holdings LLC
Generic Manufacturers
CHARTWELL RX SCIENCES LLCRISING PHARMA HOLDINGS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.